Home / Private raises / Ansa Biotechnologies, Inc.

Ansa Biotechnologies, Inc.

Biotechnology · Emeryville, California · $54.4M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$54.4M$71.9M18506(b)EquityOct 16SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedEmeryville, California
EntityCorporation
IncorporatedDelaware
SEC CIK1816722

People named in the latest filing

NameRole
Jason T GammackExecutive Officer, Director
Daniel Lin-ArlowExecutive Officer, Director
Yanniv DoroneDirector
Brad CrutchfieldDirector
Nate CornellDirector
Nick NaclerioDirector
Chenny ZhangDirector
Matthias ArenskotterExecutive Officer
Geoff HamiltonExecutive Officer
Sebastian PallukExecutive Officer

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?